HERON THERAPEUTICS, INC. /DE/ - 8-K Filing
Heron Therapeutics enters into Asset Purchase Agreement with CorMedix Inc. to sell substantially all assets for $145 million cash, 14.58 million shares of CorMedix stock, and milestone royalties. (Items: 1.01 Entry into a Material Definitive Agreement, 3.03 Material Modification to Rights of Security Holders, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $HRTX